Ma et al. found CD73 to be a potential marker for CSC recognition in HCC, overexpression of CD73 rendered HCC cells significantly resistant to rosuvastatin, and purified CD73+cells showed excellent resistance compared with CD73−cells (Ma et al., 2020). The gene discussed is NT5E; the disease is hepatocellular carcinoma.